Bangladesh · Delayed Price · Currency is BDT The ACME Laboratories Company Description
The ACME Laboratories Ltd., a pharmaceutical company, engages in the manufacture, market, and distribution of generic pharmaceutical formulation products in Bangladesh.
The company offers pharmaceutical products in various therapeutic areas, such as allergic disorders, analgesic, antifribinolytic, anti-infective, antiviral, artificial sweeteners, cardiovascular, central nervous system (CNS), cough and cold, diabetes, eye care and preparations, gastroprokinetic, hepatobiliary, gastrointestinal, gynaecological, hand sanitizers, hormones and steroid, infusion products, musculoskeletal, nasal preparation, respiratory, sex stimulants, skin care, urogenital, and vitamins and minerals.
It also provides ayurvedic, and herbal and nutraceutical products. In addition, the company offers its pharmaceutical products in human drugs dosage forms, such as tablets, capsules, dry syrups, creams, ointments, powders, injections, dry powder inhalers, metered dosage inhalers, suppository, eye and nasal drops, liquids in hard gelatin, blow fill seal products, and sachet products; veterinary drugs dosage forms, including bolus, liquids, injections, and water-soluble powders; and premix and herbal drugs dosage forms comprising liquids, capsules, tablets, and creams and ointments.
It also exports its products. The ACME Laboratories Ltd. was founded in 1954 and is headquartered in Dhaka, Bangladesh.
| Country | Bangladesh |
| Founded | 1954 |
| Industry | Pharmaceutical Preparations |
| Employees | 9,301 |
| CEO | Mizanur Sinha |
Contact Details
Address: Court de la ACME Dhaka, 1207 Bangladesh | |
| Phone | 880 2 809 1051 |
| Website | acmeglobal.com |
Stock Details
| Ticker Symbol | ACMELAB |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mizanur Sinha | Chief Executive Officer |
| Kazi Badruddin | Chief Financial Officer |